nodes	percent_of_prediction	percent_of_DWPC	metapath
Protriptyline—ABCB1—melanoma	0.619	1	CbGaD
Protriptyline—CYP2D6—Vemurafenib—melanoma	0.0961	0.483	CbGbCtD
Protriptyline—ABCB1—Dactinomycin—melanoma	0.0678	0.341	CbGbCtD
Protriptyline—ABCB1—Docetaxel—melanoma	0.035	0.176	CbGbCtD
Protriptyline—Tongue discolouration—Temozolomide—melanoma	0.00404	0.0234	CcSEcCtD
Protriptyline—Drug fever—Docetaxel—melanoma	0.00389	0.0225	CcSEcCtD
Protriptyline—Extrapyramidal disorder—Temozolomide—melanoma	0.0026	0.015	CcSEcCtD
Protriptyline—Petechiae—Temozolomide—melanoma	0.00238	0.0137	CcSEcCtD
Protriptyline—Eosinophilia—Vemurafenib—melanoma	0.00238	0.0137	CcSEcCtD
Protriptyline—Neuropathy peripheral—Vemurafenib—melanoma	0.0021	0.0121	CcSEcCtD
Protriptyline—Coordination abnormal—Carmustine—melanoma	0.00206	0.0119	CcSEcCtD
Protriptyline—Coordination abnormal—Temozolomide—melanoma	0.00199	0.0115	CcSEcCtD
Protriptyline—Disorientation—Bleomycin—melanoma	0.00188	0.0109	CcSEcCtD
Protriptyline—Gynaecomastia—Carmustine—melanoma	0.00181	0.0104	CcSEcCtD
Protriptyline—Cerebrovascular accident—Bleomycin—melanoma	0.00172	0.00991	CcSEcCtD
Protriptyline—Alopecia—Vemurafenib—melanoma	0.0017	0.0098	CcSEcCtD
Protriptyline—Dysgeusia—Vemurafenib—melanoma	0.00164	0.00945	CcSEcCtD
Protriptyline—Vascular purpura—Temozolomide—melanoma	0.00159	0.00916	CcSEcCtD
Protriptyline—Purpura—Temozolomide—melanoma	0.00147	0.0085	CcSEcCtD
Protriptyline—Pancytopenia—Bleomycin—melanoma	0.00138	0.00797	CcSEcCtD
Protriptyline—Ataxia—Carmustine—melanoma	0.00138	0.00797	CcSEcCtD
Protriptyline—Ataxia—Temozolomide—melanoma	0.00133	0.0077	CcSEcCtD
Protriptyline—Pancytopenia—Dactinomycin—melanoma	0.00129	0.00744	CcSEcCtD
Protriptyline—Acute coronary syndrome—Bleomycin—melanoma	0.00128	0.00738	CcSEcCtD
Protriptyline—Hypotension—Vemurafenib—melanoma	0.00127	0.00736	CcSEcCtD
Protriptyline—Myocardial infarction—Bleomycin—melanoma	0.00127	0.00734	CcSEcCtD
Protriptyline—Stomatitis—Bleomycin—melanoma	0.00126	0.0073	CcSEcCtD
Protriptyline—Pancytopenia—Carmustine—melanoma	0.0012	0.00696	CcSEcCtD
Protriptyline—Decreased appetite—Vemurafenib—melanoma	0.00119	0.00685	CcSEcCtD
Protriptyline—Stomatitis—Dactinomycin—melanoma	0.00118	0.0068	CcSEcCtD
Protriptyline—Fatigue—Vemurafenib—melanoma	0.00118	0.00679	CcSEcCtD
Protriptyline—Constipation—Vemurafenib—melanoma	0.00117	0.00674	CcSEcCtD
Protriptyline—Pancytopenia—Temozolomide—melanoma	0.00116	0.00672	CcSEcCtD
Protriptyline—Hypoaesthesia—Bleomycin—melanoma	0.00116	0.00669	CcSEcCtD
Protriptyline—Pollakiuria—Temozolomide—melanoma	0.00113	0.00654	CcSEcCtD
Protriptyline—Erectile dysfunction—Temozolomide—melanoma	0.00113	0.00652	CcSEcCtD
Protriptyline—Agranulocytosis—Dactinomycin—melanoma	0.00113	0.00651	CcSEcCtD
Protriptyline—Weight increased—Temozolomide—melanoma	0.00112	0.00644	CcSEcCtD
Protriptyline—Neuropathy peripheral—Carmustine—melanoma	0.00111	0.0064	CcSEcCtD
Protriptyline—Stomatitis—Carmustine—melanoma	0.0011	0.00637	CcSEcCtD
Protriptyline—Flushing—Bleomycin—melanoma	0.00108	0.00624	CcSEcCtD
Protriptyline—Body temperature increased—Vemurafenib—melanoma	0.00108	0.00623	CcSEcCtD
Protriptyline—Neuropathy peripheral—Temozolomide—melanoma	0.00107	0.00619	CcSEcCtD
Protriptyline—Stomatitis—Temozolomide—melanoma	0.00107	0.00615	CcSEcCtD
Protriptyline—Alopecia—Bleomycin—melanoma	0.00103	0.00594	CcSEcCtD
Protriptyline—Hallucination—Carmustine—melanoma	0.00101	0.00584	CcSEcCtD
Protriptyline—Hypoaesthesia—Carmustine—melanoma	0.00101	0.00584	CcSEcCtD
Protriptyline—Flushing—Dactinomycin—melanoma	0.00101	0.00582	CcSEcCtD
Protriptyline—Asthenia—Vemurafenib—melanoma	0.000979	0.00565	CcSEcCtD
Protriptyline—Hallucination—Temozolomide—melanoma	0.000976	0.00564	CcSEcCtD
Protriptyline—Hypoaesthesia—Temozolomide—melanoma	0.000976	0.00564	CcSEcCtD
Protriptyline—Pruritus—Vemurafenib—melanoma	0.000965	0.00557	CcSEcCtD
Protriptyline—Alopecia—Dactinomycin—melanoma	0.000959	0.00554	CcSEcCtD
Protriptyline—Flushing—Carmustine—melanoma	0.000943	0.00544	CcSEcCtD
Protriptyline—Ill-defined disorder—Bleomycin—melanoma	0.00094	0.00543	CcSEcCtD
Protriptyline—Diarrhoea—Vemurafenib—melanoma	0.000933	0.00539	CcSEcCtD
Protriptyline—Tinnitus—Temozolomide—melanoma	0.000915	0.00528	CcSEcCtD
Protriptyline—Malaise—Bleomycin—melanoma	0.000913	0.00527	CcSEcCtD
Protriptyline—Flushing—Temozolomide—melanoma	0.000911	0.00526	CcSEcCtD
Protriptyline—Arrhythmia—Carmustine—melanoma	0.000907	0.00524	CcSEcCtD
Protriptyline—Leukopenia—Bleomycin—melanoma	0.000907	0.00524	CcSEcCtD
Protriptyline—Dizziness—Vemurafenib—melanoma	0.000902	0.00521	CcSEcCtD
Protriptyline—Alopecia—Carmustine—melanoma	0.000897	0.00518	CcSEcCtD
Protriptyline—Ataxia—Docetaxel—melanoma	0.000887	0.00512	CcSEcCtD
Protriptyline—Ill-defined disorder—Dactinomycin—melanoma	0.000876	0.00506	CcSEcCtD
Protriptyline—Vomiting—Vemurafenib—melanoma	0.000867	0.00501	CcSEcCtD
Protriptyline—Alopecia—Temozolomide—melanoma	0.000867	0.00501	CcSEcCtD
Protriptyline—Orthostatic hypotension—Docetaxel—melanoma	0.000862	0.00498	CcSEcCtD
Protriptyline—Rash—Vemurafenib—melanoma	0.00086	0.00497	CcSEcCtD
Protriptyline—Dermatitis—Vemurafenib—melanoma	0.000859	0.00496	CcSEcCtD
Protriptyline—Headache—Vemurafenib—melanoma	0.000855	0.00494	CcSEcCtD
Protriptyline—Discomfort—Bleomycin—melanoma	0.000852	0.00492	CcSEcCtD
Protriptyline—Malaise—Dactinomycin—melanoma	0.000852	0.00492	CcSEcCtD
Protriptyline—Leukopenia—Dactinomycin—melanoma	0.000846	0.00488	CcSEcCtD
Protriptyline—Dysgeusia—Temozolomide—melanoma	0.000837	0.00483	CcSEcCtD
Protriptyline—Confusional state—Bleomycin—melanoma	0.000833	0.00481	CcSEcCtD
Protriptyline—Vision blurred—Carmustine—melanoma	0.000833	0.00481	CcSEcCtD
Protriptyline—Tremor—Carmustine—melanoma	0.000828	0.00478	CcSEcCtD
Protriptyline—Oedema—Bleomycin—melanoma	0.000827	0.00477	CcSEcCtD
Protriptyline—Agitation—Carmustine—melanoma	0.000812	0.00469	CcSEcCtD
Protriptyline—Nausea—Vemurafenib—melanoma	0.00081	0.00468	CcSEcCtD
Protriptyline—Thrombocytopenia—Bleomycin—melanoma	0.000809	0.00467	CcSEcCtD
Protriptyline—Vision blurred—Temozolomide—melanoma	0.000805	0.00465	CcSEcCtD
Protriptyline—Tremor—Temozolomide—melanoma	0.0008	0.00462	CcSEcCtD
Protriptyline—Discomfort—Dactinomycin—melanoma	0.000795	0.00459	CcSEcCtD
Protriptyline—Ill-defined disorder—Temozolomide—melanoma	0.000793	0.00458	CcSEcCtD
Protriptyline—Leukopenia—Carmustine—melanoma	0.000791	0.00457	CcSEcCtD
Protriptyline—Anorexia—Bleomycin—melanoma	0.000788	0.00455	CcSEcCtD
Protriptyline—Agitation—Temozolomide—melanoma	0.000785	0.00453	CcSEcCtD
Protriptyline—Pancytopenia—Docetaxel—melanoma	0.000774	0.00447	CcSEcCtD
Protriptyline—Hypotension—Bleomycin—melanoma	0.000772	0.00446	CcSEcCtD
Protriptyline—Oedema—Dactinomycin—melanoma	0.000771	0.00445	CcSEcCtD
Protriptyline—Malaise—Temozolomide—melanoma	0.00077	0.00445	CcSEcCtD
Protriptyline—Convulsion—Carmustine—melanoma	0.000766	0.00442	CcSEcCtD
Protriptyline—Leukopenia—Temozolomide—melanoma	0.000765	0.00442	CcSEcCtD
Protriptyline—Hypertension—Carmustine—melanoma	0.000763	0.00441	CcSEcCtD
Protriptyline—Palpitations—Temozolomide—melanoma	0.000755	0.00436	CcSEcCtD
Protriptyline—Thrombocytopenia—Dactinomycin—melanoma	0.000755	0.00436	CcSEcCtD
Protriptyline—Anxiety—Carmustine—melanoma	0.00075	0.00433	CcSEcCtD
Protriptyline—Paraesthesia—Bleomycin—melanoma	0.000742	0.00429	CcSEcCtD
Protriptyline—Weight increased—Docetaxel—melanoma	0.000742	0.00429	CcSEcCtD
Protriptyline—Convulsion—Temozolomide—melanoma	0.00074	0.00427	CcSEcCtD
Protriptyline—Hypertension—Temozolomide—melanoma	0.000738	0.00426	CcSEcCtD
Protriptyline—Anorexia—Dactinomycin—melanoma	0.000735	0.00424	CcSEcCtD
Protriptyline—Confusional state—Carmustine—melanoma	0.000728	0.0042	CcSEcCtD
Protriptyline—Anxiety—Temozolomide—melanoma	0.000725	0.00419	CcSEcCtD
Protriptyline—Oedema—Carmustine—melanoma	0.000722	0.00417	CcSEcCtD
Protriptyline—Discomfort—Temozolomide—melanoma	0.000719	0.00415	CcSEcCtD
Protriptyline—Decreased appetite—Bleomycin—melanoma	0.000719	0.00415	CcSEcCtD
Protriptyline—Acute coronary syndrome—Docetaxel—melanoma	0.000717	0.00414	CcSEcCtD
Protriptyline—Neuropathy peripheral—Docetaxel—melanoma	0.000713	0.00412	CcSEcCtD
Protriptyline—Myocardial infarction—Docetaxel—melanoma	0.000713	0.00412	CcSEcCtD
Protriptyline—Dry mouth—Temozolomide—melanoma	0.000711	0.00411	CcSEcCtD
Protriptyline—Jaundice—Docetaxel—melanoma	0.000709	0.00409	CcSEcCtD
Protriptyline—Stomatitis—Docetaxel—melanoma	0.000709	0.00409	CcSEcCtD
Protriptyline—Thrombocytopenia—Carmustine—melanoma	0.000706	0.00408	CcSEcCtD
Protriptyline—Tachycardia—Carmustine—melanoma	0.000704	0.00407	CcSEcCtD
Protriptyline—Confusional state—Temozolomide—melanoma	0.000703	0.00406	CcSEcCtD
Protriptyline—Oedema—Temozolomide—melanoma	0.000697	0.00403	CcSEcCtD
Protriptyline—Anorexia—Carmustine—melanoma	0.000688	0.00397	CcSEcCtD
Protriptyline—Thrombocytopenia—Temozolomide—melanoma	0.000683	0.00394	CcSEcCtD
Protriptyline—Feeling abnormal—Bleomycin—melanoma	0.000681	0.00393	CcSEcCtD
Protriptyline—Agranulocytosis—Docetaxel—melanoma	0.000678	0.00392	CcSEcCtD
Protriptyline—Hypotension—Carmustine—melanoma	0.000674	0.00389	CcSEcCtD
Protriptyline—Decreased appetite—Dactinomycin—melanoma	0.00067	0.00387	CcSEcCtD
Protriptyline—Fatigue—Dactinomycin—melanoma	0.000665	0.00384	CcSEcCtD
Protriptyline—Anorexia—Temozolomide—melanoma	0.000665	0.00384	CcSEcCtD
Protriptyline—Urticaria—Bleomycin—melanoma	0.000657	0.00379	CcSEcCtD
Protriptyline—Body temperature increased—Bleomycin—melanoma	0.000653	0.00377	CcSEcCtD
Protriptyline—Insomnia—Carmustine—melanoma	0.000653	0.00377	CcSEcCtD
Protriptyline—Hypoaesthesia—Docetaxel—melanoma	0.000649	0.00375	CcSEcCtD
Protriptyline—Paraesthesia—Carmustine—melanoma	0.000648	0.00374	CcSEcCtD
Protriptyline—Somnolence—Carmustine—melanoma	0.000641	0.0037	CcSEcCtD
Protriptyline—Feeling abnormal—Dactinomycin—melanoma	0.000635	0.00367	CcSEcCtD
Protriptyline—Insomnia—Temozolomide—melanoma	0.000631	0.00364	CcSEcCtD
Protriptyline—Decreased appetite—Carmustine—melanoma	0.000627	0.00362	CcSEcCtD
Protriptyline—Paraesthesia—Temozolomide—melanoma	0.000626	0.00362	CcSEcCtD
Protriptyline—Somnolence—Temozolomide—melanoma	0.00062	0.00358	CcSEcCtD
Protriptyline—Constipation—Carmustine—melanoma	0.000617	0.00356	CcSEcCtD
Protriptyline—Dyspepsia—Temozolomide—melanoma	0.000614	0.00354	CcSEcCtD
Protriptyline—Body temperature increased—Dactinomycin—melanoma	0.000609	0.00352	CcSEcCtD
Protriptyline—Abdominal pain—Dactinomycin—melanoma	0.000609	0.00352	CcSEcCtD
Protriptyline—Decreased appetite—Temozolomide—melanoma	0.000606	0.0035	CcSEcCtD
Protriptyline—Flushing—Docetaxel—melanoma	0.000606	0.0035	CcSEcCtD
Protriptyline—Fatigue—Temozolomide—melanoma	0.000601	0.00347	CcSEcCtD
Protriptyline—Constipation—Temozolomide—melanoma	0.000596	0.00344	CcSEcCtD
Protriptyline—Feeling abnormal—Carmustine—melanoma	0.000595	0.00343	CcSEcCtD
Protriptyline—Asthenia—Bleomycin—melanoma	0.000593	0.00343	CcSEcCtD
Protriptyline—Pruritus—Bleomycin—melanoma	0.000585	0.00338	CcSEcCtD
Protriptyline—Arrhythmia—Docetaxel—melanoma	0.000583	0.00337	CcSEcCtD
Protriptyline—Alopecia—Docetaxel—melanoma	0.000577	0.00333	CcSEcCtD
Protriptyline—Feeling abnormal—Temozolomide—melanoma	0.000575	0.00332	CcSEcCtD
Protriptyline—Body temperature increased—Carmustine—melanoma	0.00057	0.00329	CcSEcCtD
Protriptyline—Abdominal pain—Carmustine—melanoma	0.00057	0.00329	CcSEcCtD
Protriptyline—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A11—melanoma	0.000568	0.065	CbGpPWpGaD
Protriptyline—Dysgeusia—Docetaxel—melanoma	0.000556	0.00321	CcSEcCtD
Protriptyline—Urticaria—Temozolomide—melanoma	0.000554	0.0032	CcSEcCtD
Protriptyline—Asthenia—Dactinomycin—melanoma	0.000553	0.00319	CcSEcCtD
Protriptyline—Body temperature increased—Temozolomide—melanoma	0.000551	0.00318	CcSEcCtD
Protriptyline—Abdominal pain—Temozolomide—melanoma	0.000551	0.00318	CcSEcCtD
Protriptyline—Diarrhoea—Dactinomycin—melanoma	0.000527	0.00305	CcSEcCtD
Protriptyline—Vomiting—Bleomycin—melanoma	0.000526	0.00304	CcSEcCtD
Protriptyline—Rash—Bleomycin—melanoma	0.000521	0.00301	CcSEcCtD
Protriptyline—Dermatitis—Bleomycin—melanoma	0.000521	0.00301	CcSEcCtD
Protriptyline—Asthenia—Carmustine—melanoma	0.000518	0.00299	CcSEcCtD
Protriptyline—Leukopenia—Docetaxel—melanoma	0.000509	0.00294	CcSEcCtD
Protriptyline—Palpitations—Docetaxel—melanoma	0.000502	0.0029	CcSEcCtD
Protriptyline—Asthenia—Temozolomide—melanoma	0.0005	0.00289	CcSEcCtD
Protriptyline—Diarrhoea—Carmustine—melanoma	0.000494	0.00285	CcSEcCtD
Protriptyline—Pruritus—Temozolomide—melanoma	0.000493	0.00285	CcSEcCtD
Protriptyline—Convulsion—Docetaxel—melanoma	0.000492	0.00284	CcSEcCtD
Protriptyline—Nausea—Bleomycin—melanoma	0.000491	0.00284	CcSEcCtD
Protriptyline—Hypertension—Docetaxel—melanoma	0.000491	0.00283	CcSEcCtD
Protriptyline—Vomiting—Dactinomycin—melanoma	0.00049	0.00283	CcSEcCtD
Protriptyline—Rash—Dactinomycin—melanoma	0.000486	0.00281	CcSEcCtD
Protriptyline—Dizziness—Carmustine—melanoma	0.000477	0.00276	CcSEcCtD
Protriptyline—Diarrhoea—Temozolomide—melanoma	0.000477	0.00276	CcSEcCtD
Protriptyline—Dry mouth—Docetaxel—melanoma	0.000473	0.00273	CcSEcCtD
Protriptyline—Confusional state—Docetaxel—melanoma	0.000468	0.0027	CcSEcCtD
Protriptyline—Oedema—Docetaxel—melanoma	0.000464	0.00268	CcSEcCtD
Protriptyline—Dizziness—Temozolomide—melanoma	0.000461	0.00266	CcSEcCtD
Protriptyline—Vomiting—Carmustine—melanoma	0.000459	0.00265	CcSEcCtD
Protriptyline—Nausea—Dactinomycin—melanoma	0.000458	0.00264	CcSEcCtD
Protriptyline—Rash—Carmustine—melanoma	0.000455	0.00263	CcSEcCtD
Protriptyline—Dermatitis—Carmustine—melanoma	0.000455	0.00262	CcSEcCtD
Protriptyline—Thrombocytopenia—Docetaxel—melanoma	0.000454	0.00262	CcSEcCtD
Protriptyline—Tachycardia—Docetaxel—melanoma	0.000453	0.00261	CcSEcCtD
Protriptyline—Headache—Carmustine—melanoma	0.000452	0.00261	CcSEcCtD
Protriptyline—Vomiting—Temozolomide—melanoma	0.000443	0.00256	CcSEcCtD
Protriptyline—Anorexia—Docetaxel—melanoma	0.000442	0.00255	CcSEcCtD
Protriptyline—Rash—Temozolomide—melanoma	0.00044	0.00254	CcSEcCtD
Protriptyline—Dermatitis—Temozolomide—melanoma	0.000439	0.00254	CcSEcCtD
Protriptyline—Headache—Temozolomide—melanoma	0.000437	0.00252	CcSEcCtD
Protriptyline—Hypotension—Docetaxel—melanoma	0.000433	0.0025	CcSEcCtD
Protriptyline—Nausea—Carmustine—melanoma	0.000429	0.00248	CcSEcCtD
Protriptyline—Insomnia—Docetaxel—melanoma	0.000419	0.00242	CcSEcCtD
Protriptyline—Paraesthesia—Docetaxel—melanoma	0.000416	0.0024	CcSEcCtD
Protriptyline—Nausea—Temozolomide—melanoma	0.000414	0.00239	CcSEcCtD
Protriptyline—Somnolence—Docetaxel—melanoma	0.000412	0.00238	CcSEcCtD
Protriptyline—Dyspepsia—Docetaxel—melanoma	0.000408	0.00236	CcSEcCtD
Protriptyline—Decreased appetite—Docetaxel—melanoma	0.000403	0.00233	CcSEcCtD
Protriptyline—Fatigue—Docetaxel—melanoma	0.0004	0.00231	CcSEcCtD
Protriptyline—Constipation—Docetaxel—melanoma	0.000397	0.00229	CcSEcCtD
Protriptyline—SLC6A2—Amine compound SLC transporters—SLC6A11—melanoma	0.000394	0.0451	CbGpPWpGaD
Protriptyline—Feeling abnormal—Docetaxel—melanoma	0.000382	0.00221	CcSEcCtD
Protriptyline—Abdominal pain—Docetaxel—melanoma	0.000367	0.00212	CcSEcCtD
Protriptyline—Body temperature increased—Docetaxel—melanoma	0.000367	0.00212	CcSEcCtD
Protriptyline—Asthenia—Docetaxel—melanoma	0.000333	0.00192	CcSEcCtD
Protriptyline—SLC6A4—Serotonin Transporter Activity—ITGB3—melanoma	0.000328	0.0375	CbGpPWpGaD
Protriptyline—Pruritus—Docetaxel—melanoma	0.000328	0.00189	CcSEcCtD
Protriptyline—ABCB1—ABC-family proteins mediated transport—ABCB5—melanoma	0.000327	0.0374	CbGpPWpGaD
Protriptyline—Diarrhoea—Docetaxel—melanoma	0.000317	0.00183	CcSEcCtD
Protriptyline—Dizziness—Docetaxel—melanoma	0.000307	0.00177	CcSEcCtD
Protriptyline—Vomiting—Docetaxel—melanoma	0.000295	0.0017	CcSEcCtD
Protriptyline—Rash—Docetaxel—melanoma	0.000292	0.00169	CcSEcCtD
Protriptyline—Dermatitis—Docetaxel—melanoma	0.000292	0.00169	CcSEcCtD
Protriptyline—Headache—Docetaxel—melanoma	0.00029	0.00168	CcSEcCtD
Protriptyline—SLC6A4—NRF2 pathway—SLC39A12—melanoma	0.000282	0.0322	CbGpPWpGaD
Protriptyline—Nausea—Docetaxel—melanoma	0.000275	0.00159	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—SLC39A12—melanoma	0.000242	0.0277	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—POU3F2—melanoma	0.000202	0.0231	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—RAI1—melanoma	0.000185	0.0212	CbGpPWpGaD
Protriptyline—CYP2D6—Codeine and Morphine Metabolism—ABCB1—melanoma	0.000164	0.0188	CbGpPWpGaD
Protriptyline—CYP2D6—Melatonin metabolism and effects—MAP2—melanoma	0.000159	0.0182	CbGpPWpGaD
Protriptyline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000154	0.0176	CbGpPWpGaD
Protriptyline—SLC6A4—Monoamine Transport—ITGB3—melanoma	0.00014	0.016	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—EPHA2—melanoma	0.000138	0.0157	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—SLC6A11—melanoma	0.000129	0.0148	CbGpPWpGaD
Protriptyline—SLC6A2—Monoamine Transport—ITGB3—melanoma	0.00012	0.0137	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—EPHA2—melanoma	0.000118	0.0135	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—MAP2—melanoma	0.000116	0.0133	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—SLC6A11—melanoma	0.000111	0.0127	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—ARNT—melanoma	0.00011	0.0126	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—PAX4—melanoma	0.000106	0.0122	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—ARNT—melanoma	0.000102	0.0116	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—TP73—melanoma	9.88e-05	0.0113	CbGpPWpGaD
Protriptyline—ABCB1—Drug Induction of Bile Acid Pathway—VDR—melanoma	9.52e-05	0.0109	CbGpPWpGaD
Protriptyline—CYP2D6—Tamoxifen metabolism—CYP1B1—melanoma	9.22e-05	0.0105	CbGpPWpGaD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC15A2—melanoma	8.02e-05	0.00917	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ABCB5—melanoma	7.76e-05	0.00887	CbGpPWpGaD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	7.72e-05	0.00883	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—NDRG1—melanoma	7.45e-05	0.00852	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—MCL1—melanoma	7.45e-05	0.00852	CbGpPWpGaD
Protriptyline—CYP2D6—Melatonin metabolism and effects—CYP1B1—melanoma	7.12e-05	0.00814	CbGpPWpGaD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	7.01e-05	0.00801	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—UGT2B10—melanoma	6.11e-05	0.00699	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—melanoma	6.09e-05	0.00697	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—SLC5A5—melanoma	5.91e-05	0.00676	CbGpPWpGaD
Protriptyline—CYP2D6—Melatonin metabolism and effects—EDN1—melanoma	5.76e-05	0.00658	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	5.62e-05	0.00643	CbGpPWpGaD
Protriptyline—SLC6A4—Monoamine Transport—TNF—melanoma	5.61e-05	0.00642	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	5.57e-05	0.00637	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	5.55e-05	0.00634	CbGpPWpGaD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	5.47e-05	0.00625	CbGpPWpGaD
Protriptyline—CYP2D6—Melatonin metabolism and effects—PRKCA—melanoma	5.39e-05	0.00617	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ARL2—melanoma	5.38e-05	0.00615	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—SLC5A5—melanoma	5.08e-05	0.00581	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—FOXP3—melanoma	5.06e-05	0.00579	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	5.03e-05	0.00575	CbGpPWpGaD
Protriptyline—SLC6A2—Monoamine Transport—TNF—melanoma	4.82e-05	0.00552	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—GNA11—melanoma	4.76e-05	0.00544	CbGpPWpGaD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	4.73e-05	0.00541	CbGpPWpGaD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—melanoma	4.67e-05	0.00534	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—HDAC2—melanoma	4.47e-05	0.00511	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	4.43e-05	0.00507	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—GNAQ—melanoma	4.42e-05	0.00506	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—HGF—melanoma	4.38e-05	0.00501	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—IL10—melanoma	4.15e-05	0.00475	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	4.13e-05	0.00472	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—NGFR—melanoma	4.08e-05	0.00467	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC15A2—melanoma	4.07e-05	0.00466	CbGpPWpGaD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	3.98e-05	0.00455	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	3.95e-05	0.00452	CbGpPWpGaD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—melanoma	3.93e-05	0.00449	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC17A5—melanoma	3.92e-05	0.00448	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—AKR1B10—melanoma	3.88e-05	0.00444	CbGpPWpGaD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	3.83e-05	0.00438	CbGpPWpGaD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	3.81e-05	0.00436	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	3.8e-05	0.00435	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—HGF—melanoma	3.76e-05	0.0043	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC6A11—melanoma	3.56e-05	0.00407	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—HIF1A—melanoma	3.5e-05	0.004	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CTLA4—melanoma	3.48e-05	0.00398	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	3.41e-05	0.00391	CbGpPWpGaD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	3.23e-05	0.00369	CbGpPWpGaD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.2e-05	0.00366	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	3.18e-05	0.00364	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	3.16e-05	0.00362	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—FAS—melanoma	3.04e-05	0.00347	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	2.95e-05	0.00337	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	2.84e-05	0.00324	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	2.84e-05	0.00324	CbGpPWpGaD
Protriptyline—CYP2D6—Melatonin metabolism and effects—NFKB1—melanoma	2.78e-05	0.00318	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CD86—melanoma	2.76e-05	0.00316	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	2.76e-05	0.00315	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IL10—melanoma	2.71e-05	0.0031	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—CDK4—melanoma	2.67e-05	0.00306	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	2.64e-05	0.00301	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IL4—melanoma	2.64e-05	0.00301	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	2.62e-05	0.003	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—NOS2—melanoma	2.6e-05	0.00297	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—PDGFRA—melanoma	2.59e-05	0.00297	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—HLA-B—melanoma	2.58e-05	0.00295	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	2.54e-05	0.00291	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—FASLG—melanoma	2.52e-05	0.00288	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—PPARG—melanoma	2.43e-05	0.00278	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—FAS—melanoma	2.43e-05	0.00278	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	2.41e-05	0.00276	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	2.4e-05	0.00274	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—HLA-A—melanoma	2.39e-05	0.00273	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	2.37e-05	0.00271	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—CXCL8—melanoma	2.27e-05	0.0026	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	2.18e-05	0.00249	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—CASP3—melanoma	2.17e-05	0.00248	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	2.12e-05	0.00242	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—melanoma	2.09e-05	0.00239	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—CYP17A1—melanoma	2.04e-05	0.00233	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—NFKB1—melanoma	2.03e-05	0.00232	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CD80—melanoma	2.02e-05	0.0023	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	2.01e-05	0.0023	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CASP8—melanoma	1.87e-05	0.00214	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—melanoma	1.84e-05	0.00211	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	1.79e-05	0.00205	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	1.73e-05	0.00197	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—CYP1B1—melanoma	1.71e-05	0.00196	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	1.69e-05	0.00193	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—PTEN—melanoma	1.67e-05	0.00191	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.63e-05	0.00186	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	1.62e-05	0.00185	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IFNG—melanoma	1.59e-05	0.00182	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—TNF—melanoma	1.58e-05	0.00181	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	1.57e-05	0.00179	CbGpPWpGaD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—ALB—melanoma	1.53e-05	0.00175	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CXCL8—melanoma	1.48e-05	0.00169	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CASP3—melanoma	1.42e-05	0.00162	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IL2—melanoma	1.42e-05	0.00162	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	1.41e-05	0.00161	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	1.39e-05	0.00159	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	1.32e-05	0.00151	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	1.29e-05	0.00148	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	1.28e-05	0.00146	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—IL6—melanoma	1.27e-05	0.00146	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	1.27e-05	0.00145	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	1.24e-05	0.00142	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ABCB1—melanoma	1.24e-05	0.00142	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	1.22e-05	0.0014	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ACER3—melanoma	1.21e-05	0.00139	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—VEGFA—melanoma	1.2e-05	0.00138	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	1.2e-05	0.00137	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	1.17e-05	0.00134	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ACER3—melanoma	1.14e-05	0.00131	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—TP53—melanoma	1.14e-05	0.0013	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	1.12e-05	0.00128	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—UGT2B10—melanoma	1.11e-05	0.00127	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	1.06e-05	0.00121	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.05e-05	0.00121	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—UGT2B10—melanoma	1.04e-05	0.00119	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—IL6—melanoma	1.04e-05	0.00119	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—TNF—melanoma	1.03e-05	0.00118	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—HS3ST5—melanoma	1.03e-05	0.00118	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	9.93e-06	0.00114	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	9.81e-06	0.00112	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—HS3ST5—melanoma	9.71e-06	0.00111	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	9.24e-06	0.00106	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	9.09e-06	0.00104	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	8.86e-06	0.00101	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	8.78e-06	0.001	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	8.35e-06	0.000955	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	7.93e-06	0.000907	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	7.82e-06	0.000894	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PLCB4—melanoma	7.81e-06	0.000893	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ALB—melanoma	7.77e-06	0.000888	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	7.71e-06	0.000881	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	7.54e-06	0.000862	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PLCB4—melanoma	7.36e-06	0.000842	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIP4K2A—melanoma	7.34e-06	0.00084	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—SLC6A11—melanoma	7.34e-06	0.00084	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	7.17e-06	0.00082	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—MTAP—melanoma	7.14e-06	0.000817	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	7.14e-06	0.000816	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	7e-06	0.0008	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—SLC6A11—melanoma	6.92e-06	0.000791	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIP4K2A—melanoma	6.92e-06	0.000791	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	6.81e-06	0.000779	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	6.74e-06	0.000771	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—MTAP—melanoma	6.73e-06	0.00077	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	6.59e-06	0.000753	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	6.57e-06	0.000752	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	6.54e-06	0.000748	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—LUM—melanoma	6.37e-06	0.000728	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PHGDH—melanoma	6.37e-06	0.000728	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—HPSE—melanoma	6.24e-06	0.000714	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CUBN—melanoma	6.13e-06	0.000701	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PHGDH—melanoma	6e-06	0.000686	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—LUM—melanoma	6e-06	0.000686	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.94e-06	0.000679	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—SDHD—melanoma	5.92e-06	0.000677	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—BSG—melanoma	5.92e-06	0.000677	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CSPG4—melanoma	5.92e-06	0.000677	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—HPSE—melanoma	5.88e-06	0.000673	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CUBN—melanoma	5.78e-06	0.000661	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GPAM—melanoma	5.73e-06	0.000656	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.62e-06	0.000642	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—BSG—melanoma	5.58e-06	0.000638	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—SDHD—melanoma	5.58e-06	0.000638	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CSPG4—melanoma	5.58e-06	0.000638	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	5.46e-06	0.000625	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GPAM—melanoma	5.4e-06	0.000618	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	5.34e-06	0.000611	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	5.34e-06	0.000611	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	5.09e-06	0.000582	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	5.05e-06	0.000577	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PLA2G6—melanoma	4.87e-06	0.000557	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.64e-06	0.00053	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PLA2G6—melanoma	4.59e-06	0.000525	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.49e-06	0.000513	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—VCAN—melanoma	4.38e-06	0.000501	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—VCAN—melanoma	4.13e-06	0.000472	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.79e-06	0.000433	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP17A1—melanoma	3.69e-06	0.000423	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GNA11—melanoma	3.49e-06	0.000399	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP17A1—melanoma	3.48e-06	0.000398	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	3.42e-06	0.000391	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—FASN—melanoma	3.41e-06	0.00039	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—SLC5A5—melanoma	3.36e-06	0.000384	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GNA11—melanoma	3.29e-06	0.000376	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GNAQ—melanoma	3.24e-06	0.000371	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CD44—melanoma	3.24e-06	0.000371	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—FASN—melanoma	3.22e-06	0.000368	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—SLC5A5—melanoma	3.16e-06	0.000362	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP1B1—melanoma	3.11e-06	0.000356	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GNAQ—melanoma	3.06e-06	0.00035	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CD44—melanoma	3.06e-06	0.00035	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP1B1—melanoma	2.93e-06	0.000335	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ABCB1—melanoma	2.41e-06	0.000276	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PRKCA—melanoma	2.36e-06	0.00027	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ERCC2—melanoma	2.34e-06	0.000267	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PRKCA—melanoma	2.22e-06	0.000254	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ERCC2—melanoma	2.2e-06	0.000252	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CG—melanoma	1.85e-06	0.000211	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PPARG—melanoma	1.78e-06	0.000204	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CG—melanoma	1.74e-06	0.000199	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PPARG—melanoma	1.68e-06	0.000192	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CD—melanoma	1.62e-06	0.000186	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ALB—melanoma	1.6e-06	0.000183	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CD—melanoma	1.53e-06	0.000175	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ALB—melanoma	1.51e-06	0.000173	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CB—melanoma	1.41e-06	0.000162	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTGS2—melanoma	1.4e-06	0.00016	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CB—melanoma	1.33e-06	0.000152	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTGS2—melanoma	1.32e-06	0.000151	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTEN—melanoma	1.22e-06	0.00014	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTEN—melanoma	1.15e-06	0.000132	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CA—melanoma	8.62e-07	9.86e-05	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CA—melanoma	8.13e-07	9.29e-05	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—AKT1—melanoma	7.04e-07	8.06e-05	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—AKT1—melanoma	6.64e-07	7.59e-05	CbGpPWpGaD
